Latest Sales Growth News

RooLife Group Ltd has successfully raised $2 million through an oversubscribed strategic placement, positioning the company to expand its e-commerce footprint across key international markets.

DroneShield launches SentryCiv, a subscription-based AI-powered counter-drone solution designed to protect civilian critical infrastructure from emerging aerial threats.

JB Hi-Fi reported a robust FY25 with 10% sales growth and increased dividends, while preparing for a leadership change.

Nick Scali Limited reported a resilient FY25 with solid sales growth in Australia and New Zealand, while UK operations continue to improve margins despite ongoing losses. The company declared a fully franked dividend and outlined plans for further expansion.

Nick Scali Limited reported a solid FY25 underlying profit of $62 million, driven by strong ANZ sales and online growth, while UK operations continue to struggle amid store refurbishments and brand repositioning.

Neuren Pharmaceuticals reports a 16% rise in Q2 2025 royalties driven by Acadia’s DAYBUE sales growth and expanding patient base in the US. Full-year sales guidance remains strong with European market entry on the horizon.

The Calmer Co. International Limited has reported an 81% surge in retail sales through Coles in July, driven by a significant expansion in store presence and strong consumer demand for its natural relaxation products.

Nutritional Growth Solutions revises its Q2 FY25 financials, confirming stable revenue and detailing expanded distribution into CVS and Walmart. The company is actively raising capital to support growth and improve liquidity.

Vitrafy Life Sciences reported a 75% increase in FY25 sales driven by aquaculture and human health sectors, progressing its cryopreservation technology towards commercialisation in both unregulated and regulated markets in FY26.

Coventry Group’s FY25 results reveal a sharp EBITDA decline amid ERP disruptions and soft markets, prompting a major cost reduction drive for FY26.

Vitrafy Life Sciences reported strong FY25 progress with 75% sales growth, advanced cryopreservation technology development, and a robust cash position. The company outlines a clear commercialisation roadmap for FY26, including product launches and expanded U.S. operations.

Briscoe Group Limited reported a 2.07% increase in second quarter sales to $192.9 million, with online sales approaching 20% of total revenue. Despite ongoing economic challenges, the company expects a net profit after tax of at least $29 million for the first half of 2025.